For the Inventor, By the Inventor

Enter assignee name

Gyeonggi-do, South Korea

1St Biotherapeutics, Inc.

USPTO Granted Patents = 12

EPO Patents = 3

Forward Citations = 3

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Jinhwa Lee (12 out of 23 patents)

Suyeon Jo (11 out of 12 patents)

Keonseung Lim (8 out of 8 patents)

4. A Yeong Park (8 out of 8 patents)

5. Misoon Kim (8 out of 9 patents)

6. Jae Eun Kim (8 out of 22 patents)

7. Seung Mook Lim (6 out of 6 patents)

8. Hwajung Nam (4 out of 4 patents)

9. Yeonguk Jeon (3 out of 3 patents)

10. Gadhe Changdev Gorakshnath (3 out of 3 patents)

11. Yejin Hwang (3 out of 3 patents)

12. Gwibin Lee (2 out of 2 patents)

13. Wanjun Li (2 out of 2 patents)

14. Mingzhu Fan (2 out of 2 patents)

15. Inyoung Yang (2 out of 3 patents)

12 patents: Sort by Forward Citations

1. 12534461 - Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders (2026-01-27),

2. 12509458 - [F]-labeled imidazopyridine derivatives as PET radiotracer (2025-12-30),

3. 12398156 - Compounds for prevention or treatment of neurodegenerative disorders (2025-08-26),

4. 12304905 - Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof (2025-05-20),

5. 11834467 - Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors (2023-12-05),

6. 11802126 - Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders (2023-10-31),

7. 11744824 - 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds (2023-09-05),

8. 11649255 - Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same (2023-05-16),

9. 11098044 - Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders (2021-08-24),

10. 10968188 - Benzothiazol compounds and methods using the same for treating neurodegenerative disorders (2021-04-06),

11. 10669246 - Benzothiazol compounds and methods using the same for treating neurodegenerative disorders (2020-06-02),

12. 10385046 - Processes for preparing benzothiazol compounds and methods of using the same for treating neurodegenerative disorders (2019-08-20),

Company Overview

1St Biotherapeutics, Inc. is a biotechnology company based in Gyeonggi-do, South Korea, focused on the development of innovative biotherapeutic solutions. The company specializes in research and manufacturing processes aimed at advancing treatments for various diseases, leveraging cutting-edge technologies in the biopharmaceutical sector. With a commitment to improving patient outcomes, 1St Biotherapeutics engages in the exploration of novel therapeutic modalities and the optimization of existing biopharmaceutical products.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#66 in Gyeonggi-do

#936 in South Korea

#48,163 in the World

Gyeonggi-do, South Korea

1St Biotherapeutics, Inc.

Forward Citations = 3

20 inventors:

Jinhwa Lee (12 out of 23 patents)

Suyeon Jo (11 out of 12 patents)

Keonseung Lim (8 out of 8 patents)

4. A Yeong Park (8 out of 8 patents)

5. Misoon Kim (8 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: 1St Biotherapeutics, Inc.. Retrieved from https://idiyas.com/company/1st-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…